Gambaran Umum
Procter & Gamble Health Limited, formerly known as Merck Limited, is a prominent healthcare company based in India. The company operates in the pharmaceutical and wellness industry, providing a wide range of over-the-counter (OTC) products, vitamins, and decongestants. It is a subsidiary of the Procter & Gamble Company, a multinational consumer goods corporation headquartered in the United States. Procter & Gamble Health Limited is committed to delivering innovative, science-based solutions that address the evolving healthcare needs of consumers. The company has a strong distribution network and widespread presence across India, effectively reaches consumers in urban and rural areas alike. Key projects include the expansion of its product portfolio and increasing its market penetration in India. The company continually invests in research and development to create advanced healthcare solutions.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Procter & Gamble Health Limited per 2025 Jun 30 adalah 12,729.10 MM.
- Nilai operating income untuk Procter & Gamble Health Limited per 2025 Jun 30 adalah 3,868.90 MM.
- Nilai net income untuk Procter & Gamble Health Limited per 2025 Jun 30 adalah 3,005.90 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 12,729.10 | 3,868.90 | 3,005.90 |
2025-03-31 | 12,180.50 | 3,430.80 | 2,511.90 |
2024-12-31 | 11,595.40 | 3,283.50 | 2,365.70 |
2024-09-30 | 11,597.40 | 2,916.60 | 2,177.40 |
2024-06-30 | 11,512.60 | 2,791.10 | 2,009.80 |
2024-03-31 | 11,685.60 | 3,050.90 | 2,140.20 |
2023-12-31 | 12,370.00 | 2,872.70 | 2,266.50 |
2023-09-30 | 12,370.00 | 3,091.60 | 2,313.80 |
2023-06-30 | 12,296.20 | 2,958.50 | 2,294.70 |
2023-03-31 | 12,243.30 | 3,106.20 | 2,408.00 |
2022-12-31 | 11,712.30 | 3,016.30 | 2,327.70 |
2022-09-30 | 11,391.60 | 2,547.30 | 2,008.10 |
2022-06-30 | 11,144.10 | 2,425.60 | 1,925.20 |
2022-03-31 | 11,039.10 | 2,332.00 | 1,852.60 |
2021-12-31 | 10,552.40 | 1,936.10 | 1,498.70 |
2021-09-30 | 10,175.60 | 2,192.60 | 1,729.10 |
2021-06-30 | 10,087.30 | 2,172.90 | 1,768.00 |
2021-03-31 | 9,218.92 | 2,187.75 | 1,883.96 |
2020-12-31 | 9,308.48 | 2,502.16 | 2,190.88 |
2020-09-30 | 9,273.94 | 2,140.55 | 1,894.18 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 142.52 | 142.44 |
2024-09-30 | 131.17 | 131.17 |
2024-06-30 | 121.08 | 121.00 |
2024-03-31 | 128.94 | 128.70 |
2023-12-31 | 136.54 | 136.30 |
2023-09-30 | 139.44 | 139.20 |
2023-06-30 | 138.24 | 138.00 |
2023-03-31 | 145.08 | 145.08 |
2022-12-31 | 140.18 | 140.18 |
2022-09-30 | 120.90 | 120.90 |
2022-06-30 | 115.98 | 116.00 |
2022-03-31 | 111.61 | 111.61 |
2021-12-31 | 90.31 | 90.31 |
2021-09-30 | 104.20 | 104.20 |
2021-06-30 | 106.51 | |
2021-03-31 | 113.47 | 113.50 |
2020-12-31 | 131.83 | 131.86 |
2020-09-30 | 114.07 | 114.11 |
2020-06-30 | 99.87 | 99.81 |
2020-03-31 | 99.11 | 99.11 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | 2,249.20 | 127.87 | -3,129.87 |
2024-12-31 | 2,731.20 | 73.10 | -4,347.20 |
2024-09-30 | |||
2024-06-30 | 2,282.90 | -68.70 | -4,181.10 |
2024-03-31 | |||
2023-12-31 | 1,740.10 | 20.50 | -1,610.90 |
2023-09-30 | |||
2023-06-30 | 2,360.00 | -215.00 | -984.70 |
2023-03-31 | |||
2022-12-31 | 3,349.10 | -492.00 | -924.50 |
2022-09-30 | |||
2022-06-30 | 1,695.20 | -255.40 | -2,886.30 |
2022-03-31 | |||
2021-12-31 | 1,157.00 | -212.30 | -2,207.40 |
2021-09-30 | |||
2021-06-30 | 2,472.60 | -322.70 | -3,866.30 |
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 39.13.
- p/libro untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 18.31.
- p/tbv untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 18.33.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 39.13 | 18.31 | 18.33 |
2025-03-31 | 37.33 | 14.47 | 14.49 |
2024-12-31 | 40.42 | 16.35 | 16.38 |
2024-09-30 | 45.59 | 17.02 | 17.05 |
2024-06-30 | 38.98 | 10.35 | 10.36 |
2024-03-31 | 34.66 | 9.75 | 9.76 |
2023-12-31 | 45.11 | 13.90 | 13.92 |
2023-09-30 | 45.48 | 13.90 | 13.92 |
2023-06-30 | 36.11 | 11.03 | 11.05 |
2023-03-31 | 34.41 | 11.28 | 11.28 |
2022-12-31 | 52.04 | 16.95 | 16.95 |
2022-09-30 | 41.26 | 13.44 | 13.44 |
2022-06-30 | 43.04 | 13.44 | 13.44 |
2022-03-31 | 44.73 | 14.11 | 14.11 |
2021-12-31 | 55.29 | 14.11 | 14.11 |
2021-09-30 | 47.92 | 11.77 | 11.78 |
2021-06-30 | 46.87 | 11.77 | 11.78 |
2021-03-31 | 43.98 | 12.85 | 12.85 |
2020-12-31 | 37.82 | 12.85 | 12.85 |
2020-09-30 | 43.74 | 9.14 | 9.14 |
2020-06-30 | 49.94 | 9.14 | 9.14 |
2020-03-31 | 50.37 | 10.14 | 10.15 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.03.
- EBIT (3 tahun) / EV untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.03.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.03 | 0.03 |
2025-03-31 | 0.04 | 0.04 |
2024-12-31 | 0.03 | 0.04 |
2024-09-30 | 0.03 | 0.03 |
2024-06-30 | 0.04 | 0.04 |
2024-03-31 | 0.04 | 0.04 |
2023-12-31 | 0.03 | 0.03 |
2023-09-30 | 0.03 | 0.03 |
2023-06-30 | 0.04 | 0.03 |
2023-03-31 | 0.04 | 0.03 |
2022-12-31 | 0.03 | 0.02 |
2022-09-30 | 0.03 | 0.03 |
2022-06-30 | 0.03 | 0.03 |
2022-03-31 | 0.03 | 0.03 |
2021-12-31 | 0.03 | 0.03 |
2021-09-30 | 0.03 | 0.03 |
2021-06-30 | 0.03 | 0.03 |
2021-03-31 | 0.03 | 0.03 |
2020-12-31 | 0.04 | 0.03 |
2020-09-30 | 0.03 | 0.03 |
2020-06-30 | 0.03 | 0.02 |
2020-03-31 | 0.03 | 0.02 |
Efektivitas Manajemen
- roa untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.32.
- roe untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.47.
- roic untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.46.
- croic untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah -0.28.
- ocroic untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.50.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.32 | 0.47 | 0.46 | -0.28 | 0.50 |
2025-03-31 | 0.22 | 0.29 | 0.38 | -0.25 | 0.44 |
2024-12-31 | 0.20 | 0.29 | 0.40 | -0.36 | 0.42 |
2024-09-30 | 0.18 | 0.29 | 0.37 | -0.36 | 0.42 |
2024-06-30 | 0.20 | 0.29 | 0.26 | 0.02 | 0.21 |
2024-03-31 | 0.21 | 0.31 | 0.28 | 0.02 | 0.21 |
2023-12-31 | 0.26 | 0.38 | 0.30 | 0.15 | 0.31 |
2023-09-30 | 0.26 | 0.37 | 0.30 | 0.15 | 0.31 |
2023-06-30 | 0.26 | 0.37 | 0.30 | 0.15 | 0.31 |
2023-03-31 | 0.28 | 0.41 | 0.32 | 0.26 | 0.45 |
2022-12-31 | 0.20 | 0.29 | 0.32 | -0.23 | 0.27 |
2022-09-30 | 0.20 | 0.29 | 0.32 | -0.23 | 0.27 |
2022-06-30 | 0.20 | 0.27 | 0.31 | -0.23 | 0.27 |
2022-03-31 | 0.22 | 0.29 | 0.32 | -0.21 | 0.20 |
2021-12-31 | 0.18 | 0.23 | 0.25 | -0.21 | 0.20 |
2021-09-30 | 0.15 | 0.19 | 0.24 | -0.24 | 0.35 |
2021-06-30 | 0.15 | 0.20 | 0.25 | -0.24 | 0.35 |
2021-03-31 | 0.18 | 0.23 | 0.29 | 0.00 | 0.00 |
2020-12-31 | 0.21 | 0.27 | 0.33 | -0.49 | 0.24 |
2020-09-30 | 0.19 | 0.25 | 0.21 | -0.36 | 0.17 |
2020-06-30 | 0.17 | 0.22 | 0.18 | -0.36 | 0.17 |
2020-03-31 | 0.09 | 0.11 | 0.20 | -0.68 | 0.20 |
Gross Margins
- marjin kotor untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.71.
- marjin bersih untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.21.
- marjin operasi untuk Procter & Gamble Health Limited pada 2025 Jun 30 adalah 0.28.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.71 | 0.21 | 0.28 |
2025-03-31 | 0.72 | 0.20 | 0.28 |
2024-12-31 | 0.71 | 0.19 | 0.25 |
2024-09-30 | 0.71 | 0.17 | 0.24 |
2024-06-30 | 0.69 | 0.18 | 0.26 |
2024-03-31 | 0.68 | 0.18 | 0.23 |
2023-12-31 | 0.69 | 0.19 | 0.25 |
2023-09-30 | 0.71 | 0.19 | 0.24 |
2023-06-30 | 0.71 | 0.19 | 0.24 |
2023-03-31 | 0.70 | 0.20 | 0.25 |
2022-12-31 | 0.69 | 0.18 | 0.22 |
2022-09-30 | 0.69 | 0.18 | 0.22 |
2022-06-30 | 0.70 | 0.17 | 0.22 |
2022-03-31 | 0.68 | 0.17 | 0.21 |
2021-12-31 | 0.68 | 0.14 | 0.18 |
2021-09-30 | 0.69 | 0.17 | 0.21 |
2021-06-30 | 0.69 | 0.18 | 0.21 |
2021-03-31 | 0.67 | 0.20 | 0.24 |
2020-12-31 | 0.66 | 0.24 | 0.27 |
2020-09-30 | 0.64 | 0.20 | 0.23 |
2020-06-30 | 0.65 | 0.19 | 0.21 |
2020-03-31 | 0.68 | 0.18 | 0.21 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |